Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Identifying the Role of Oxytocin and Vasopressin in the Functioning of Neurocognitive Systems Involved in Mood Disorders

This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00325065
First received: May 11, 2006
Last updated: April 17, 2010
Last verified: April 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: April 2010
  Estimated Primary Completion Date: No date given